Copyright
©The Author(s) 2025.
World J Virol. Jun 25, 2025; 14(2): 106479
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.106479
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.106479
Table 3 Correlation between the index and each marker alone with factors related to treatment failure
Variable | HA × PIIINP | HA | PIIINP | |||
r | P value | r | P value | r | P value | |
ALT (U/L) | 0.182 | 0.091 | 0.127 | 0.096 | 0.121 | 0.210 |
AST (U/L) | 0.212 | 0.089a | 0.114 | 0.133 | 0.150 | 0.182 |
ALP (U/L) | 0.191 | 0.059 | 0.112 | 0.214 | 0.071 | 0.261 |
Albumin (g/dL) | -0.26 | 0.021a | -0.20 | 0.044a | -0.201 | 0.043a |
Bilirubin (mg/dL) | 0.194 | 0.062 | 0.136 | 0.079 | 0.099 | 0.223 |
Platelets (× 109/L) | -0.19 | 0.058 | -0.13 | 0.083 | -0.123 | 0.158 |
FIB-4 | 0.216 | 0.022a | 0.186 | 0.041a | 0.185 | 0.041a |
APRI | 0.223 | 0.019a | 0.188 | 0.041a | 0.181 | 0.041a |
- Citation: Abdelrazek MA, Elghwab AI, Tabll AA, Elsayed EH, El Behery M. Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals. World J Virol 2025; 14(2): 106479
- URL: https://www.wjgnet.com/2220-3249/full/v14/i2/106479.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i2.106479